Al Rifai M, Shapiro M, Sayani S, Gulati M, Levine G, Rodriguez F, Mahtta D, Khera A, Petersen LA, Virani SS. Am J Cardiol. 2020 Aug 11:S0002-9149(20)30818-3. doi: 10.1016/j.amjcard.2020.08.001
Mackenzie DG, Hudson S, Gulati M. Eur Heart J. 2020 Jul 7;41(26):2423-2427. doi: 10.1093/eurheartj/ehaa162.
Wu P, Mamas MA, Gulati M.
J Womens Health 2019;28: 1037-1050 doi:10.1089/jwh.2018.7480
Bestseller by Dr. Martha Gulati and Ms Sherry Torkos
Please contact me for speaking engagements. Please know I do not speak for pharmaceutical companies or to promote any products.
From the American College of Cardiology
Evidence is mounting on the undertreatment of women with cardiovascular disease. Women face delays in recognition of disease and compared to men are less likely to receive guideline-directed medical therapy or the right intensification of therapy.
Explore how CVD presents differently in women and how to tailor treatment strategies based on physiological differences to optimize patient outcomes.